ERA-EDTA 2019 – Budapest, Hungary
Thank you for visiting us at the 56th ERA-EDTA in Budapest, Hungary.
See you next year again in Milano, Italy. #ERAEDTA20
Menu
Nipro recognizes the importance of environmental preservation and acts conscientiously.
Active involvement in environmental issues is an essential part of corporate activity. We keep an eye on our potential impact on the global environment not in the manufacturing process alone, but in all aspects of our business activities. In our efforts to preserve and improve the environment, we pursue efficient use of resources and energy, reduction of waste and emissions, assessment and mitigation of the impact of our products and production process on the environment, and development and use of environmental technologies.
We take swift and appropriate action to alleviate any adverse impact or potential impact on the environment and to improve the environment. We also cooperate with the local community in environmental activities, and provide fair and appropriate information.
To help reduce environmental burden we promote recycling, lights-off and other conservation activities that can easily be done on a daily basis.
Nipro promotes various activities at its offices and factories to reduce burdens on the global environment. Recognizing environmental conservation as a key issue, each and every worker is actively involved in eco-friendly initiatives, such as conservation and reuse of resources, and energy-saving campaigns for lighting and air-conditioning systems.
Medical devices are now a pervasive part of modern medical care. They are in many cases associated with quality of care. Healthcare worker and patient safety are key strategies for healthcare providers. Nipro assists providers to meet this challenge by supplying a developing portfolio of next generation safety medical products aimed at reducing the risk of needlestick injuries and associated infections.
Nipro’s quality system is focused on satisfying critical specifications, continuously improving all products and complying with regulatory requirements. Regulatory services include 510(k) and technical file preparation and assistance with CE Marking.
“Our customers expect the highest quality products and materials, made for their specific needs, and delivered in a short time frame.”
Werner-von-Siemens-Str. 2-6
76646 Bruchsal – Germany
T: +49 7251 32 19 78 10
F: +49 7251 618 99 43
info@nipropurewater.com
Nipro Pure Water (NPW) manufacturers water treatment equipment and specialized furnishing for dialysis centers.
NPW is stationed in Germany.
Following is a list of countries where NPW has installed successfully reverse osmosis systems.
Eurasia: Germany, Belgium, France, Italy, Spain, Poland, Lithuania, Ukraine, UK, Bosnia, Iran, Thailand and Russia
Africa: Senegal, Mauritania, Ghana, Libya, Nigeria, Algeria, Kenya, Rwanda, South Africa and Morocco
South America: Suriname and Peru
Pol.Ind. TUMSA – nave 31
25230
Mollerusa (Lleida) – Spain
T: +34 973 306 430
info@niprorenalsolutions.com
www.niprorenalsolutions.com
Nipro Renal Solutions S.R.L was founded in Mollerussa, Spain in 1994. NRS specializes in the manufacture of concentrates for hemodialysis and is currently the leading producer of concentrates in Spain. Sustained growth over the last two decades has also positioned NRS in the international market; currently, NRS concentrates can be found in Europe, Asia, and Latin America.
NRS strives to satisfy customers’ needs by providing optimized solutions for hemodialysis through a combination of talented staff and know-how. NRS’ R&D department is fully committed to deliver safe, innovative, and high- quality dialysis concentrates tailored to meet the market’s needs.
NRS holds an EC certificate for medical devices in accordance with directive 93/42/CEE and produces European Pharmacopeia compliant products.
NRS has a strict quality management policy and is compliant with regulatory standards of product and environmental safety. Furthermore, NRS’ quality management system is implemented in accordance with UNE-EN-ISO 9001 and EN-ISO-13485. Certificates can be obtained through the links below:
In each business area of Nipro Corporation, priority is focused on building long-term partnerships with each customer. This is accomplished by providing superior quality and value throughout the business in addition to listening to customer needs and translating those needs into specific products and services. Nipro Europe constantly thrives to create and offer safe, high-quality products ensuring a better quality of life. Being recognized as a worldwide leading brand vital to the medical field of artificial organs, regenerative medicines and other medical devices, we continue to strive for growth by becoming our customer’s first choice.
…we offer an organization that is attractive and challenging. We strive for operational excellence through an experienced and talented employee base. We empower and provide our people with the resources needed to develop professionally, improving their skills, resulting in a dedicated team.
…we manage a portfolio that is focused on customer and market demand. We always strive to expand in new and current markets with innovative products and applications. By continuously increasing our positioning efforts, we enlarge our brand name recognition.
…we are a sales and marketing-focused organization, committed to continuously advancing our efficiency and improving our work to provide superior products and services.
Nipro Europe Goup Companies
Blokhuisstraat 42
2800 Mechelen
Belgium
Tel: +32 (0)15 263 500
Managing Director: Tsuyoshi Yamazaki
Remove the row
Column: 1
Units 12-14 South Point, Ensign Way
SO31 4RF Hamble, Hampshire – United Kingdom
T: +44 238 060 43 00
F: +44 238 060 43 19
UK Tax strategy <click to open>
Biopôle Clermont-Limagne
63 360 Saint Beauzire – France
T: +33 473 33 41 00
F: +33 473 33 41 09
Verlengde Poolseweg 16
4818 CL Breda – Netherlands
T: +31 (0)76 524 50 99
F: +31 (0)76 524 46 66
Ul. Pańska 73
00-834 Warszawa – Poland
T: +48 22 31 47 155
F: +48 22 31 47 152
Poligono Los Frailes n° 93 y 94
Calle los Frailles
28814 Daganzo de Arriba, Madrid – Spain
T: +34 91 878 29 21
F: +34 91 878 28 40
12 Krasnopresnenskaya Nab.
Entrance 6, Office 1407
123610 Moscow – Russia
T: +7 495 258 1364
F: +7 495 258 1365
Centro Direzionale Milanofiori
Strada 1 – Palazzo F/1
20090 Assago (Milano) – Italy
T: +39 02 57 50 00 57
F: +39 02 57 51 81 11
Divischgasse 4
1210 Wien – Austria
T: +43 1 532 23 14
F: +43 1 532 23 14 89
Column: 2
Cape Town Office
4B Dwyka Street, Stikland, Bellville, 7530 South Africa
T: +27 21 949 2635
F: +27 21 949 2397
Johannesburg Office
Unit 20 & 21, Falcon Lane, Lanseria Business Park, Erf 805 Lanseria
Corporate Estate, Pelindaba Rd., Lanseria Ext. 26, Gauteng, South Africa
T: +27 11 431 1114
F: +27 11 431 1115
Sis Route Derrière Usine Bastos-Yaoundé
BP 5535 Yaoundé – Cameroon
T: +237 677 78 72 23
F: +237 673 37 79 78
Kokkolastrasse 5
40882 Ratingen – Germany
T: + 49 2102 564 60 83
F: +49 2102 564 60 80
Kokkolastrasse 5
40882 Ratingen – Germany
T: + 49 2102 564 60 81
F: +49 2102 564 60 90
9 Adelabu Close, Off Toyin Street
100271 Ikeja, Lagos State – Nigeria
T: +234 (0)802 706 7065
Avd. Da Liberdade 249, 1° Andar
1205-143 Lisboa – Portugal
T: +34 91 878 29 21
F: +34 91 878 28 40
Bastovanska 68a
11000 Belgrade – Serbia
T: +381 11 75 15 578
F: +381 11 63 06 307
Aziziye Mah.Pilot Sok.17/ 4
6540 Çankaya-Ankara – Turkey
T: +90 312 442 21 12
F: +90 312 442 21 29
The Nipro Group promotes research and development of both medical equipment and pharmaceutical products.
Our research and development focuses on cutting-edge technologies as well as trying to achieve higher quality and improved functionality with our existing products. We expect to commercialize one of our cutting-edge products, namely our nerve regeneration-assisting device, which uses our unique bio-absorbable materials, developed in-house.
We have come close to developing a cell-culturing system thanks to our studies of stem cells in umbilical blood.
In terms of artificial organs, our range of implanted ventricular-assist devices, developed in cooperation with an American company, are currently at the clinical testing stage in Japan.
With regard to the development of new drugs and new formulation technologies, further to the commercialization of our powdered dialysis solutions based on a new and highly effective granulation technology, we plan to be the first company to commercialize a double-bag product for hemodiafiltration substitution fluids as well as selling various products such as pre-filled syringes for safety use, thereby contributing to the prevention of medical accidents.
In this consolidated accounting year, the total cost of R&D activity was 4.8 billion yen (US$ 52.1 million).
Nipro offers you the opportunity to join one of its six Business units and be part of a leading brand. Whether you are an Account Manager with Hospital Products, a Customer Services Representative at headquarters or a Clinical Support Specialist with Renal Care you will find a career with Nipro that will challenge your thinking, develop your professional skills and brings you into contact with people who share the same commitment to simplicity and service.
We’re continually seeking talented individuals at all levels. Nipro offers excellent opportunities within sales, marketing, finance and technical departments for all of its European offices.
Nipro is committed to equal opportunity in employment, and is opposed to discrimination of employees or applicants for employment, on the grounds of race, religious beliefs, colour, nationality, sex, sexual orientation, marital/parental status, age, or disability.
